首页 > 最新文献

Journal of the American College of Cardiology最新文献

英文 中文
Artificial Intelligence to Propel Evidence Generation. 人工智能推动证据生成。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-25 DOI: 10.1016/j.jacc.2025.11.011
Sanket S Dhruva, Lesley H Curtis, Robert M Califf
{"title":"Artificial Intelligence to Propel Evidence Generation.","authors":"Sanket S Dhruva, Lesley H Curtis, Robert M Califf","doi":"10.1016/j.jacc.2025.11.011","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.011","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":""},"PeriodicalIF":22.3,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Private Equity in Cardiology: A Crossroads for a New Generation of Physicians. 心脏病学的私募股权:新一代医生的十字路口。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-25 DOI: 10.1016/j.jacc.2025.11.018
Hassan A Alhassan
{"title":"Private Equity in Cardiology: A Crossroads for a New Generation of Physicians.","authors":"Hassan A Alhassan","doi":"10.1016/j.jacc.2025.11.018","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.018","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":""},"PeriodicalIF":22.3,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asian American Heart Failure Care: Why Disaggregated Subgroup Data Matters. 亚裔美国人心力衰竭护理:为什么分类亚组数据很重要。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-25 DOI: 10.1016/j.jacc.2025.11.030
Andy Y Lee, Kevin S Tang, Nathan D Wong
{"title":"Asian American Heart Failure Care: Why Disaggregated Subgroup Data Matters.","authors":"Andy Y Lee, Kevin S Tang, Nathan D Wong","doi":"10.1016/j.jacc.2025.11.030","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.030","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":""},"PeriodicalIF":22.3,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aficamten and the Future of Obstructive Hypertrophic Cardiomyopathy Management. 梗阻性肥厚性心肌病治疗的非洲和未来。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-25 DOI: 10.1016/j.jacc.2025.11.029
Sara Saberi
{"title":"Aficamten and the Future of Obstructive Hypertrophic Cardiomyopathy Management.","authors":"Sara Saberi","doi":"10.1016/j.jacc.2025.11.029","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.029","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":""},"PeriodicalIF":22.3,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Modern Era: Seeing the Forest through the Trees. 转甲状腺素淀粉样蛋白心肌病在现代的延迟诊断:透过树木看到森林。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-25 DOI: 10.1016/j.jacc.2025.11.012
Melissa A Lyle, Jose N Nativi-Nicolau
{"title":"Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Modern Era: Seeing the Forest through the Trees.","authors":"Melissa A Lyle, Jose N Nativi-Nicolau","doi":"10.1016/j.jacc.2025.11.012","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.012","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":""},"PeriodicalIF":22.3,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some Much-Needed CONFIDENCE to Combat the Risk-Treatment Paradox in Chronic Kidney Disease. 抗击慢性肾脏疾病风险-治疗悖论的一些急需的信心。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-25 DOI: 10.1016/j.jacc.2025.11.034
Daniel Edmonston
{"title":"Some Much-Needed CONFIDENCE to Combat the Risk-Treatment Paradox in Chronic Kidney Disease.","authors":"Daniel Edmonston","doi":"10.1016/j.jacc.2025.11.034","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.034","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":""},"PeriodicalIF":22.3,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Audio Summary. 音频总结。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-23 DOI: 10.1016/S0735-1097(25)10285-4
{"title":"Audio Summary.","authors":"","doi":"10.1016/S0735-1097(25)10285-4","DOIUrl":"https://doi.org/10.1016/S0735-1097(25)10285-4","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":"86 25","pages":"e201"},"PeriodicalIF":22.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145810516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Quality and Policy: What This Means as a "Report Card" on Heart Failure Care. 健康质量和政策:心脏衰竭护理的“报告卡”意味着什么?
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-23 DOI: 10.1016/j.jacc.2025.10.067
Paul Heidenreich
{"title":"Health Quality and Policy: What This Means as a \"Report Card\" on Heart Failure Care.","authors":"Paul Heidenreich","doi":"10.1016/j.jacc.2025.10.067","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.10.067","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":"86 25","pages":"2574-2576"},"PeriodicalIF":22.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145810536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction. 心肌肌球蛋白结合蛋白C在急性心肌梗死早期诊断中的增量价值。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-23 Epub Date: 2025-11-12 DOI: 10.1016/j.jacc.2025.09.008
Pedro Lopez-Ayala, Jasper Boeddinghaus, Luca Koechlin, Paolo Bima, Jonas Glaeser, Carlos C Spagnuolo, Luca Crisanti, Oscar Miro, Francisco Javier Martín-Sánchez, Michael Christ, Karin Wildi, Simona Piazza, Thomas Nestelberger, Maria Rubini Gimenez, Juliane Gehrke, Jude Formambuh, Emel Kaplan, Gabrielle Hure, Tobias Breidthardt, Evangelos Giannitsis, Bertil Lindahl, Michael Marber, Felix Mahfoud, Ivo Strebel, Christian Mueller

Background: Cardiac myosin-binding protein C (cMyC) is a cardiac-specific sarcomeric protein with faster release kinetics compared with those of high-sensitivity cardiac troponin (hs-cTn).

Objectives: The aim of this study was to compare the diagnostic performance of cMyC, measured with a novel prototype automated immunoassay, with high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity cardiac troponin I (hs-cTnI) for the early diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI). Furthermore, we derived a single blood draw dual-biomarker strategy combining hs-cTn and cMyC and compared it with the hs-cTnT/I-only strategy endorsed by the European Society of Cardiology.

Methods: This was a secondary analysis from an international prospective study recruiting adult patients presenting to the emergency department (ED) with suspected NSTEMI. cMyC, hs-cTnT, and hs-cTnI concentrations were measured upon ED presentation. Final diagnoses were centrally adjudicated by 2 independent cardiologists blinded to cMyC values. To compare the single- and dual-biomarker strategy, safety (defined as the sensitivity and negative predictive value for ruling out index NSTEMI) and triage efficacy (defined as the proportion of patients triaged to either rule-out or rule-in) were assessed. The diagnostic endpoint was index NSTEMI. The prognostic endpoint was 30-day, 1-year, and 5-year cardiovascular death or MI. Findings were externally validated in an independent international cohort.

Results: Among 4,735 eligible patients, 854 (18%) were diagnosed with NSTEMI. The discrimination for NSTEMI at presentation was higher for cMyC (area under the curve [AUC]: 0.943; 95% CI: 0.936-0.95) than for hs-cTnT (AUC: 0.936; 95% CI: 0.929-0.944; P = 0.008). Differences were mainly driven by patients with chest pain onset ≤3 hours (AUC of 0.939 [95% CI: 0.928-0.951] vs 0.921 [95% CI: 0.907-0.936], respectively; P < 0.001). The dual-biomarker strategy increased overall triage efficacy from 26.8% (hs-cTnT only) to 60.0% (hs-cTnT and cMyC), without compromising safety during the index visit. Despite identifying up to 3 times more patients for rule-out, the dual-biomarker strategy showed comparable cumulative incidences of cardiovascular death or myocardial infarction at 30 days, 1 year, and 5 years. Similar results were observed with hs-cTnI and in the external validation cohort.

Conclusions: CMyC adds significant incremental value to hs-cTn values in the early diagnosis of NSTEMI, improving diagnostic discrimination and enabling more patients to be safely and immediately ruled out for NSTEMI. The single blood draw dual-biomarker strategy is particularly attractive in busy ED settings due to its simplicity and quick time-to-decision. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE]; NCT00470587).

背景:心肌肌球蛋白结合蛋白C (cMyC)是一种心肌特异性肌肉蛋白,与高敏感性心肌肌钙蛋白(hs-cTn)相比,其释放动力学更快。目的:本研究的目的是比较cMyC的诊断性能,用一种新型原型自动免疫测定法测量,与高灵敏度心肌肌钙蛋白T (hs-cTnT)和高灵敏度心肌肌钙蛋白I (hs-cTnI)在非st段抬高型心肌梗死(NSTEMI)的早期诊断。此外,我们得出了一种结合hs-cTn和cMyC的单血双生物标志物策略,并将其与欧洲心脏病学会认可的hs-cTnT/I-only策略进行了比较。方法:这是一项国际前瞻性研究的二级分析,该研究招募了疑似NSTEMI的急诊成年患者。cMyC、hs-cTnT和hs-cTnI浓度在ED表现时测定。最终诊断由2名不了解cMyC值的独立心脏病专家集中裁决。为了比较单一和双重生物标志物策略,评估了安全性(定义为排除指数NSTEMI的敏感性和阴性预测值)和分诊疗效(定义为排除或纳入分诊的患者比例)。诊断终点为索引NSTEMI。预后终点为30天、1年和5年心血管死亡或心肌梗死。研究结果在一个独立的国际队列中得到了外部验证。结果:在4735例符合条件的患者中,854例(18%)被诊断为NSTEMI。cMyC对NSTEMI的鉴别率(曲线下面积[AUC]: 0.943; 95% CI: 0.936-0.95)高于hs-cTnT (AUC: 0.936; 95% CI: 0.929-0.944; P = 0.008)。差异主要由患者胸痛发作≤3小时引起(AUC分别为0.939 [95% CI: 0.928-0.951]和0.921 [95% CI: 0.907-0.936], P < 0.001)。双生物标志物策略将总体分诊效率从26.8%(仅hs-cTnT)提高到60.0% (hs-cTnT和cMyC),在索引访问期间不影响安全性。尽管确定排除的患者多出3倍,但双生物标志物策略显示,30天、1年和5年心血管死亡或心肌梗死的累积发生率相当。在hs-cTnI和外部验证队列中观察到类似的结果。结论:CMyC在NSTEMI早期诊断中为hs-cTn值增加了显著的增量价值,提高了诊断辨析,使更多的患者能够安全并立即排除NSTEMI。单次抽血双生物标志物策略因其简单和快速决策而在繁忙的急诊科环境中特别具有吸引力。急性冠脉综合征评价的有利预测因素[APACE]; NCT00470587)。
{"title":"Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction.","authors":"Pedro Lopez-Ayala, Jasper Boeddinghaus, Luca Koechlin, Paolo Bima, Jonas Glaeser, Carlos C Spagnuolo, Luca Crisanti, Oscar Miro, Francisco Javier Martín-Sánchez, Michael Christ, Karin Wildi, Simona Piazza, Thomas Nestelberger, Maria Rubini Gimenez, Juliane Gehrke, Jude Formambuh, Emel Kaplan, Gabrielle Hure, Tobias Breidthardt, Evangelos Giannitsis, Bertil Lindahl, Michael Marber, Felix Mahfoud, Ivo Strebel, Christian Mueller","doi":"10.1016/j.jacc.2025.09.008","DOIUrl":"10.1016/j.jacc.2025.09.008","url":null,"abstract":"<p><strong>Background: </strong>Cardiac myosin-binding protein C (cMyC) is a cardiac-specific sarcomeric protein with faster release kinetics compared with those of high-sensitivity cardiac troponin (hs-cTn).</p><p><strong>Objectives: </strong>The aim of this study was to compare the diagnostic performance of cMyC, measured with a novel prototype automated immunoassay, with high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity cardiac troponin I (hs-cTnI) for the early diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI). Furthermore, we derived a single blood draw dual-biomarker strategy combining hs-cTn and cMyC and compared it with the hs-cTnT/I-only strategy endorsed by the European Society of Cardiology.</p><p><strong>Methods: </strong>This was a secondary analysis from an international prospective study recruiting adult patients presenting to the emergency department (ED) with suspected NSTEMI. cMyC, hs-cTnT, and hs-cTnI concentrations were measured upon ED presentation. Final diagnoses were centrally adjudicated by 2 independent cardiologists blinded to cMyC values. To compare the single- and dual-biomarker strategy, safety (defined as the sensitivity and negative predictive value for ruling out index NSTEMI) and triage efficacy (defined as the proportion of patients triaged to either rule-out or rule-in) were assessed. The diagnostic endpoint was index NSTEMI. The prognostic endpoint was 30-day, 1-year, and 5-year cardiovascular death or MI. Findings were externally validated in an independent international cohort.</p><p><strong>Results: </strong>Among 4,735 eligible patients, 854 (18%) were diagnosed with NSTEMI. The discrimination for NSTEMI at presentation was higher for cMyC (area under the curve [AUC]: 0.943; 95% CI: 0.936-0.95) than for hs-cTnT (AUC: 0.936; 95% CI: 0.929-0.944; P = 0.008). Differences were mainly driven by patients with chest pain onset ≤3 hours (AUC of 0.939 [95% CI: 0.928-0.951] vs 0.921 [95% CI: 0.907-0.936], respectively; P < 0.001). The dual-biomarker strategy increased overall triage efficacy from 26.8% (hs-cTnT only) to 60.0% (hs-cTnT and cMyC), without compromising safety during the index visit. Despite identifying up to 3 times more patients for rule-out, the dual-biomarker strategy showed comparable cumulative incidences of cardiovascular death or myocardial infarction at 30 days, 1 year, and 5 years. Similar results were observed with hs-cTnI and in the external validation cohort.</p><p><strong>Conclusions: </strong>CMyC adds significant incremental value to hs-cTn values in the early diagnosis of NSTEMI, improving diagnostic discrimination and enabling more patients to be safely and immediately ruled out for NSTEMI. The single blood draw dual-biomarker strategy is particularly attractive in busy ED settings due to its simplicity and quick time-to-decision. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE]; NCT00470587).</p>","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":" ","pages":"2616-2632"},"PeriodicalIF":22.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145495834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Defines Reward in Influenza Vaccination. 流感疫苗接种风险决定回报。
IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-23 DOI: 10.1016/j.jacc.2025.11.010
Ole Fröbert
{"title":"Risk Defines Reward in Influenza Vaccination.","authors":"Ole Fröbert","doi":"10.1016/j.jacc.2025.11.010","DOIUrl":"https://doi.org/10.1016/j.jacc.2025.11.010","url":null,"abstract":"","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":"86 25","pages":"2648-2650"},"PeriodicalIF":22.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145810517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American College of Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1